Your browser doesn't support javascript.
loading
Applications of Nanoparticle-Antibody Conjugates in Immunoassays and Tumor Imaging.
Lin, Xinhao; O'Reilly Beringhs, André; Lu, Xiuling.
Affiliation
  • Lin X; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut, USA.
  • O'Reilly Beringhs A; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut, USA.
  • Lu X; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut, USA. xiuling.lu@uconn.edu.
AAPS J ; 23(2): 43, 2021 03 14.
Article in En | MEDLINE | ID: mdl-33718979
ABSTRACT
Modern diagnostic technologies rely on both in vitro and in vivo modalities to provide a complete understanding of the clinical state of a patient. Nanoparticle-antibody conjugates have emerged as promising systems to confer increased sensitivity and accuracy for in vitro diagnostics (e.g., immunoassays). Meanwhile, in vivo applications have benefited from the targeting ability of nanoparticle-antibody conjugates, as well as payload flexibility and tailored biodistribution. This review provides an encompassing overview of nanoparticle-antibody conjugates, from chemistry to applications in medical immunoassays and tumor imaging, highlighting the underlying principles and unique features of relevant preclinical applications employing commonly used imaging modalities (e.g., optical/photoacoustics, positron-emission tomography, magnetic resonance imaging, X-ray computed tomography).
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoassay / Immunoconjugates / Metal Nanoparticles / Neoplasms Limits: Humans Language: En Journal: AAPS J Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoassay / Immunoconjugates / Metal Nanoparticles / Neoplasms Limits: Humans Language: En Journal: AAPS J Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: